NAS:ACAD () Also Trade In: Germany Mexico

ACADIA Pharmaceuticals Inc $ 43.27 1.7 (4.09%)

Volume:
1,207,434
Avg Vol (1m):
2,015,751
Market Cap $:
6.74 Bil
Enterprise Value $:
6.10 Bil
P/E (TTM):
0.00
P/B:
10.53
Warning! GuruFocus has detected 2 Medium warning signs with ACAD. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

ACADIA Pharmaceuticals Inc News and Headlines -

GuruFocus Articles Total 14
  • 1

Companies need to demonstrate they can be successful in new therapeutic areas

In a previous article, we looked at the Pharmaceutical Innovation Index and how there was no correlation between some of the companies at the top of the list and their stock performance.

One glaring example is Gilead Sciences Inc. (GILD), which was rated the most innovative in 2019. The company’s share price has dropped nearly 19% in the past two years, though it has made somewhat of a comeback this year with a gain of $5 to nearly $66.

Mike Rea, CEO of IDEA Pharma, the U.K-based consulting firm that publishes the annual index, told me in a phone

186 Views    Barry Cohen    2019-09-20 16:10
Danish pharmaceutical company needs, but seemingly can’t afford, bigger acquisitions

Danish pharmaceutical company H. Lundbeck A/S (OCSE:LUN) is searching for ways to renew investor optimism. But with the company seemingly priced out of some badly needed acquisitions, it’s going to have to scramble to avoid further erosion in its share price.

On the heels of disappointing first-quarter results, Lundbeck shares dropped below $42 on May 8. That means in the past 10 months, the company has lost more than 40% of its market value. The shares declined 3.6% on Feb. 5 alone when the drugmaker said it would pay 30% to 60% of net profit in dividends instead of

279 Views    Barry Cohen    2019-05-08 20:51
Loxo Oncology tops the list

According to the GuruFocus All-In-One Screener, the following health care stocks are popular among guru investors.

Seven gurus are invested in Loxo Oncology Inc. (LOXO). The company develops medicines for patients with genetically defined cancers. It has a market cap of $5.12 billion.

The stock is trading with a price-book ratio of 12.91. The current price of $167 is 20.48% below its 52-week high and 132.54% above its 52-week low. Over the last 10 years, it has returned a gain of 1,184%.

The company’s largest shareholder among the gurus is Frank Sands (Trades, Portfolio) with 6.59%

133 Views    Tiziano Frateschi    2018-09-06 19:14
Billionaire investor takes stake in clinical-stage gene therapy company

Guru investor Steven Cohen (Trades, Portfolio), who heads up the multibillion-dollar hedge fund Point72 Asset Management, disclosed he established a 5.2% stake in Nightstar Therapeutics Ltd. (NITE) on Aug. 6, adding to his holdings in the health care space.

With approximately $13 billion in assets under management, the Connecticut-based firm seeks to deliver superior risk-adjusted returns using long, short, macro and systematic strategies. Cohen founded Point72 in 2014 after his former hedge fund, S.A.C. Capital Advisors, was shut down following an insider trading investigation.

According to GuruFocus real-time picks, Cohen invested in 1.5 million shares of

466 Views    Sydnee Gatewood    2018-08-08 18:37
Guru boosts position 170%

Point72 fund manager Steven Cohen (Trades, Portfolio) disclosed on Monday that he increased his C&J Energy Services (CJ) holding by 170%.

According to GuruFocus real-time picks, Cohen invested in 2,205,212 shares for $23.36 per share, expanding the position to 3,501,802 shares. The manager increased his portfolio 0.21% with the transaction.

3be4a0d9ab84b3665aecbfba2032cb8c.png

Company background

C&J Energy Services provides a wide variety of services to the oil and gas industry, including hydraulic fracturing, wireline logging, pressure pumping and pressure testing.

The Houston-based company listed three reportable segments in its March quarterly report: Completion Services,

142 Views    James Li    2018-07-11 19:14
Pfizer, Delphi Technologies rise, Acadia Pharmaceuticals falls

Shares of Pfizer Inc. (PFE) advanced despite President Donald Trump criticizing the company in a tweet for increasing the prices of some of its prescription drugs.

Trump said that companies were "merely taking advantage of the poor and others unable to defend themselves, while at the same time giving bargain basement prices to other countries in Europe and elsewhere." Pfizer raised prices for 100 products a few days ago, weeks after the president promised price reductions.

Acadia Pharmaceuticals Inc. (ACAD) fell more than 7% on Monday after a report by the Southern Investigative Reporting Foundation's Roddy Boyd raised concerns about

45 Views    Omar Venerio    2018-07-09 20:26
The FDA said it would re-examine the company's only drug

Point72 Chairman and CEO [url=http://www.gurufocus.com/StockBuy.php?GuruName=Steven+Cohen]Steven Cohen[/url] ([url=http://www.gurufocus.com/StockBuy.php?GuruName=Steven+Cohen]Trades[/url], [url=http://www.gurufocus.com/holdings.php?GuruName=Steven+Cohen]Portfolio[/url]) has increased his position in Acadia Pharmaceuticals (ACAD), a developer of treatments targeting central nervous system disorders, by 45.6% as the price dropped, GuruFocus Real Time Picks data showed Tuesday.

Cohen’s purchase consisted of 1,987,174 shares and raised his aggregate holding to 6,344,600 shares, giving him a 5.08% stake in the company. His execution price around $16 on June 15 was substantially below the stock’s first-quarter average price of $28 due to a 46% plunge year to date.

Part of the decline in price related to a Food and Drug Administration’s re-examination

1059 Views    Holly LaFon    2018-06-20 16:53
Gurus are buying these popular stocks

According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.

Four gurus are invested in Acadia Pharmaceuticals Inc. (ACAD).

The biopharmaceutical company has a market cap of $3.99 billion.

The stock is trading with a price-book (P/B) ratio of 10.42. The current stock price of $32.13 is 22.01% below its 52-week high and 28.21% above its 52-week low. Over the past 10 years, it has returned a gain of 201%.

The company’s largest shareholder among the gurus is Paul Singer (Trades, Portfolio) with 0.86% of outstanding shares, followed by Steven

297 Views    Tiziano Frateschi    2018-01-29 21:24
ImmunoGen falls, Acadia rises

On Wednesday, U.S. stock market indexes closed in the green after opening lower. The S&P 500 and the Dow Jones Industrial Average recorded highs. The S&P 500 rose 0.12% points to close at 2,537.74, the Nasdaq Composite gained 0.04% to 6,534.63 and the Dow Jones increased 0.09% to 22,661.64.

Shares of ImmunoGen Inc. (IMGN) closed 2.35% higher on Wednesday, but fell more than 8% in after-hours trading after announcing a secondary offering of 13 million shares. The biotech company plans to use the proceeds to finance research and development, clinical trials and other expenses like commercialization preparation, acquisitions

216 Views    Omar Venerio    2017-10-04 21:43
Largest insider trades of the week

The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$5,000,000+,” the duration to “February 2017” and All Insider Sales to “$5,000,000+.”

According to the above filters, the following are trades from company insiders this week.

Elliott International LP, 10% owner of Arconic Inc. (ARNC), bought a total of 289,000 shares for $29.23 per share on Feb 15 and 16. Since then, the stock price has increased 0.9% to $29.49.

Arconic develops and manufactures engineered products and solutions for the aerospace,

317 Views    Tiziano Frateschi    2017-02-17 21:34

Andreas Halvorsen (Trades, Portfolio)’s hedge fund Viking Global Investors increased its stake in pharmaceutical company Esperion Therapeutics (ESPR) by 875.1% on June 18, GuruFocus Real Time Picks reported Monday.

Founded in 2008, Esperion makes treatments for heart disease patients who experience intolerable side effects from existing drugs. Halvorsen holds 1,335,101 shares of the company, a 5.9% stake, after the increase. He began the position in the first quarter with 136,919 shares.

Esperion’s share price rose more than 406% over the past 12 months as one of its treatments, ETC-1002, advanced toward FDA approval

2040 Views    Holly LaFon    2015-06-30 03:18

The shares of the Acadia Pharmaceuticals (ACAD) are in trouble waters as it has slipped by over 20% on extremely high volumes yesterday. There are reasons at play behind this sudden nosedive and analysts believe them to be the lackadaisical move by the pharmaceutical company itself that pushed the sales in a dungeon.

The company was previously researching on the Parkinson disease psychosis drug Nuplazid which was about to be launched during this quarter in the second half of the year and was further delayed citing issues with their competency to manufacture the drug on a commercial scale, raised

973 Views    reports.droy    2015-03-15 00:41

Acadia Pharmaceuticals (ACAD) is making headlines with the sudden announcement of the CEO’s retirement and an application delay for the company’s leading drug. Acadia focuses on developing treatment for neurological and central nervous system disorders.

On March 11, CEO Uli Hacksell abruptly retired after 16 years with the company. He will also be retiring from his position on the board of directors. Acadia applauded Hacksell’s tenure in a press release, noting that Acadia “has grown from a small startup to a fast growing biopharmaceutical company with innovative drug candidates” under his leadership. CFO Steve David will take over immediately

382 Views    TipRanks    2015-03-13 13:54
According to [url=http://www.gurufocus.com/InsiderBuy.php]GuruFocus Insider Data[/url], the largest CFO sells during the past week were: Coca-Cola Co., Krispy Kreme Doughnuts Inc., Pier 1 Imports Inc., NPS Pharmaceuticals Inc. and ARCADIA Pharmaceuticals Inc. [b]Coca-Cola Co. (KO): Executive Vice President and CFO Gary P. Fayard Sold 224,000 Shares[/b] Executive Vice President and CFO [url=http://www.gurufocus.com/InsiderBuy.php?insider=FAYARD+GARY+P]Gary P. Fayard[/url] sold 224,000 shares of KO stock on 04/09/2013 at the average price of $41. Gary P. Fayard owns at least 545,541 shares after this. The price of the stock has increased by 0.2% since. The Coca-Cola Co. was incorporated in September 1919 under the laws of the
484 Views    Jimmy Xiao    2013-04-16 14:31

Headlines Total 81
  • 1

2020-08-03 $ 43.27 (4.09%)
12:09pm
11:08am
11:03am
2020-07-29 $ 42.53 (-1.44%)
11:33am
9:34am
9:21am
2020-07-28 $ 43.15 (-2.66%)
10:33am
2020-07-27 $ 44.33 (2%)
9:25am
9:09am
2020-07-24 $ 43.46 (-0.66%)
12:13pm
12:08pm
11:52am
11:45am
9:16am
2020-07-23 $ 43.75 (1.93%)
1:35pm
11:58am
11:45am
10:15am
10:09am
2020-07-22 $ 42.92 (-3.96%)
11:32am
2020-07-20 $ 55.42 (0.82%)
10:17am
2020-07-09 $ 56.07 (-0.59%)
6:15pm
2020-07-07 $ 53.69 (4.03%)
11:07pm
2020-06-24 $ 52.02 (-1.35%)
6:49am
2020-06-23 $ 52.73 (0.78%)
12:52pm
2020-06-16 $ 47.34 (1.83%)
9:47am
2020-06-08
8:01pm
2020-06-06
10:31am
2020-06-02 $ 48.02 (-1.78%)
7:27am
2020-05-29 $ 49.68 (-1.99%)
6:00am
2020-05-27 $ 50.63 (-1.06%)
11:15am
2020-05-16 $ 50.83 (7.33%)
7:15pm
2020-05-15 $ 50.83 (7.33%)
11:18am
2020-05-12 $ 49.37 (-2.99%)
12:41pm
2020-05-08 $ 50.72 (2.8%)
9:55am
11:38pm
2020-05-07 $ 49.34 (2.41%)
5:45pm
5:10pm
2020-05-06 $ 48.18 (1.69%)
12:35pm
2020-05-05 $ 47.38 (1.7%)
10:40am
8:56am
2020-05-04 $ 46.59 (3.69%)
4:12pm
2020-05-01 $ 44.93 (-7%)
5:15pm
2020-04-30 $ 48.31 (-4.83%)
11:34am
2020-03-27 $ 38.83 (-1.75%)
10:31am
2020-03-26 $ 39.52 (3.84%)
5:15am
2019-12-13 $ 44.34 (-0.4%)
5:15pm
2019-12-12 $ 45.01 (-2.7%)
6:15pm
2019-12-07 $ 51.4 (1.82%)
6:15pm
2019-10-11 $ 40.52 (0.1%)
5:15pm
2019-01-12 $ 21.08 (1.79%)
7:00pm
2018-09-17 $ 14.05 (1.22%)
11:03am
2018-09-15 $ 13.88 (0.87%)
7:01pm
2018-09-14 $ 13.76 (-0.07%)
7:02pm
2018-09-08
3:01pm
7:01pm
2018-09-07 $ 14.04 (0.07%)
3:01pm
2018-09-05 $ 14.24 (0.14%)
7:02pm
7:01pm
2018-09-01 $ 14.22 (-1.39%)
11:00pm
7:00pm
2018-08-31 $ 14.42 (%)
7:00pm
2018-08-25 $ 14.39 (0.91%)
7:00pm
2018-08-24 $ 14.26 (0.56%)
7:01pm
2018-08-19
11:00pm
2018-08-18
7:01am
2018-08-17 $ 13.03 (-2.03%)
11:02am
2018-08-15 $ 14.33 (0.28%)
7:03pm
2018-08-11
11:00am
2018-08-04 $ 15.22 (-1.74%)
11:00pm
7:00pm
7:00pm
2018-07-25 $ 16.05 (0.38%)
3:00pm
7:01pm
2018-07-24 $ 15.99 (-2.91%)
3:02pm
2018-07-21 $ 16.84 (-1.41%)
7:01pm
2018-07-09 $ 16.63 (-6.78%)
3:26pm
3 Stocks Move Monday - GuruFocus.com
2018-06-20 $ 17.05 (4.41%)
11:53am
2015-03-15
7:41pm
2015-03-13 $ 34.45 (-1.06%)
8:54am
2009-05-12 $ 1.93 (6.63%)
10:09pm
Total 81
  • 1